The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements
详细信息 查看全文
- 作者：Einat Avital Schmutz ; Michael Bruce Zimmermann…
- 关键词：Vitamin D ; Vitamin A ; Mortality ; NHANES III
- 刊名：European Journal of Nutrition
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：55
- 期：1
- 页码：393-402
- 全文大小：551 KB
- 参考文献：1.Pilz S, Tomaschitz A, Marz W, Drechsler C, Ritz E, Zittermann A, Cavalier E, Pieber TR, Lappe JM, Grant WB, Holick MF, Dekker JM (2011) Vitamin D, cardiovascular disease and mortality. Clin Endocrinol 75(5):575–584. doi:10.1111/J.1365-2265.2011.04147.X CrossRef
2.Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66(9):1137–1142. doi:10.1136/ard.2007.069831 CrossRef
3.Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Guerin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9(11):709–715. doi:10.1016/j.autrev.2010.06.009 CrossRef
4.Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91(5):1255–1260. doi:10.3945/ajcn.2009.29094 CrossRef
5.Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML (2010) Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 5(6):e11088. doi:10.1371/journal.pone.0011088 CrossRef
6.Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ (2014) The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. doi:10.1038/nrc3691
7.Welsh J (2012) Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys 523(1):107–114. doi:10.1016/J.Abb.2011.10.019 CrossRef
8.Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S (2012) Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 95(1):91–100. doi:10.3945/ajcn.111.014779 CrossRef
9.Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. doi:10.1056/NEJMra070553 CrossRef
10.Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348:g1903. doi:10.1136/bmj.g1903 CrossRef
11.Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune function. Nutrients 5(7):2502–2521. doi:10.3390/Nu5072502 CrossRef
12.Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 76(3):315–325. doi:10.1111/j.1365-2265.2011.04261.x CrossRef
13.Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94(1):26–34. doi:10.1210/jc.2008-1454 CrossRef
14.Lee S, Clark SA, Gill RK, Christakos S (1994) 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 134(4):1602–1610. doi:10.1210/endo.134.4.8137721
15.Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin–angiotensin system. J Clin Investig 110(2):229–238. doi:10.1172/JCI15219 CrossRef
16.Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, Group IOFCoSANW (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820. doi:10.1007/s00198-009-0954-6 CrossRef
17.Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK (1997) The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 154(Suppl):S57–S73
18.Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR (1998) Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. J Biol Chem 273(14):8483–8491CrossRef
19.Cheng TY, Neuhouser ML (2012) Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient–nutrient interaction. Cancer Causes Control 23(9):1557–1565. doi:10.1007/s10552-012-0033-8 CrossRef
20.Cheng TY, Lacroix AZ, Beresford SA, Goodman GE, Thornquist MD, Zheng Y, Chlebowski RT, Ho GY, Neuhouser ML (2013) Vitamin D intake and lung cancer risk in the women’s health initiative. Am J Clin Nutr 98(4):1002–1011. doi:10.3945/ajcn.112.055905 CrossRef
21.Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL (2007) Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 165(10):1178–1186. doi:10.1093/aje/kwm026 CrossRef
22.Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer 102(9):1422–1427. doi:10.1038/sj.bjc.6605658 CrossRef
23.National Center for Health Statistics (1994) Plan and operation of the third National Health and Nutrition Examination Survey, 1988–94. vol 32. Natl Ctr for Health Statistics
24.Dukas L, Platz EA, Colditz GA, Willet WC, Giovannucci EL (2000) Bowel movement, use of laxatives and risk of colorectal adenomatous polyps among women (United States). Cancer Causes Control 11(10):907–914CrossRef
25.European Commission, Scientific Committee on Food (2002) Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Preformed Vitamin A (retinol and retinyl esters)
26.Blomhoff R, Beckman-Sundh U, Brot C, Solvoll C, Steingrimsdóttir L, Carlsen MH (2003) Health risks related to high intake of preformed retinol (vitamin A) in the Nordic countries. Nordic Council of Ministers
27.Ballew C, Galuska D, Gillespie C (2001) High serum retinyl esters are not associated with reduced bone mineral density in the third national health and nutrition examination survey, 1988–1994. J Bone Miner Res 16(12):2306–2312. doi:10.1359/jbmr.2001.16.12.2306 CrossRef
28.Willett W (2013) Nutritional epidemiology, vol 40. Oxford University Press, Oxford
29.Krasinski SD, Russell RM, Otradovec CL, Sadowski JA, Hartz SC, Jacob RA, McGandy RB (1989) Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, alpha-tocopherol, and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A-supplement users. Am J Clin Nutr 49(1):112–120
30.Smith FR, Goodman DS (1976) Vitamin A transport in human vitamin A toxicity. N Engl J Med 294(15):805–808. doi:10.1056/NEJM197604082941503 CrossRef
31.Schottker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L, Streppel M, Gardiner J, Ordonez-Mena JM, Perna L, Wilsgaard T, Rathmann W, Feskens E, Kampman E, Siganos G, Njolstad I, Mathiesen EB, Kubinova R, Pajak A, Topor-Madry R, Tamosiunas A, Hughes M, Kee F, Bobak M, Trichopoulou A, Boffetta P, Brenner H, Consortium on H, Ageing: Network of Cohorts in E, the United S (2014) Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348:g3656. doi:10.1136/bmj.g3656 CrossRef
32.Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470. doi:10.1002/14651858.CD007470.pub3
33.Rush L, McCartney G, Walsh D, Mackay D (2013) Vitamin D and subsequent all-age and premature mortality: a systematic review. BMC Public Health 13(1):679. doi:10.1186/1471-2458-13-679 CrossRef
34.Schottker B, Ball D, Gellert C, Brenner H (2013) Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 12(2):708–718. doi:10.1016/j.arr.2012.02.004 CrossRef
35.Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD (2012) Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5(6):819–829. doi:10.1161/CIRCOUTCOMES.112.967604 CrossRef
36.Pilz S, Tomaschitz A, Obermayer-Pietsch B, Dobnig H, Pieber TR (2009) Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 29(9):3699–3704
37.Bikle DD (2014) Vitamin D and cancer: the promise not yet fulfilled. Endocrine 46(1):29–38. doi:10.1007/s12020-013-0146-1 CrossRef
38.Michaelsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundstrom J, Berglund L, Arnlov J, Hellman P, Blomhoff R, Wolk A, Garmo H, Holmberg L, Melhus H (2010) Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 92(4):841–848. doi:10.3945/ajcn.2010.29749 CrossRef
39.Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121(2):469–477. doi:10.1007/s10549-009-0593-9 CrossRef
40.Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128(6):1414–1424. doi:10.1002/ijc.25439 CrossRef
41.Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L, Bekkering GE, Fraser WD, Sterne JA, Metcalfe C (2011) Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. Cancer Causes Control 22(3):319–340. doi:10.1007/s10552-010-9706-3 CrossRef
42.Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29(28):3775–3782. doi:10.1200/JCO.2011.35.7566 CrossRef
43.Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2011) Meta-analysis: serum vitamin D and colorectal adenoma risk. Prev Med 53(1–2):10–16. doi:10.1016/j.ypmed.2011.05.013 CrossRef
44.Yin L, Ordonez-Mena JM, Chen T, Schottker B, Arndt V, Brenner H (2013) Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Prev Med 57(6):753–764. doi:10.1016/j.ypmed.2013.08.026 CrossRef
45.Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168(15):1629–1637. doi:10.1001/archinte.168.15.1629 CrossRef
46.Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57(9):1595–1603. doi:10.1111/j.1532-5415.2009.02359.x CrossRef
47.Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI (2010) Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res 70(21):8587–8597. doi:10.1158/0008-5472.CAN-10-1420 CrossRef
48.Ragavan VV, Smith JE, Bilezikian JP (1982) Vitamin A toxicity and hypercalcemia. Am J Med Sci 283(3):161–164CrossRef
49.Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D (2011) Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study. PLoS One 6(6):e20796. doi:10.1371/journal.pone.0020796 CrossRef
50.Cheng TY, Goodman GE, Thornquist MD, Barnett MJ, Beresford SA, Lacroix AZ, Zheng Y, Neuhouser ML (2014) Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers. Int J Cancer. doi:10.1002/ijc.28846
51.Bates CJ, Hamer M, Mishra GD (2012) A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Osteopor Int 23(2):457–466. doi:10.1007/s00198-011-1543-z CrossRef
52.Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, Jenny NS, Siscovick DS (2011) Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 58(14):1433–1441. doi:10.1016/j.jacc.2011.03.069 CrossRef
53.Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R (2010) Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur J Endocrinol 162(5):935–942. doi:10.1530/EJE-09-1041 CrossRef
54.Rohrmann S, Braun J, Bopp M, Faeh D, Swiss National C (2013) Inverse association between circulating vitamin D and mortality-dependent on sex and cause of death? Nutr Metab Cardiovasc Dis 23(10):960–966. doi:10.1016/j.numecd.2013.05.005 CrossRef
55.Zou A, Elgort MG, Allegretto EA (1997) Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3. J Biol Chem 272(30):19027–19034CrossRef
56.Arnhold T, Tzimas G, Wittfoht W, Plonait S, Nau H (1996) Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption. Life Sci 59(12):PL169–PL177CrossRef
57.Millen AE, Dodd KW, Subar AF (2004) Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc 104(6):942–950. doi:10.1016/j.jada.2004.03.022 CrossRef
58.Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, Betz JM, Sempos CT, Picciano MF (2011) Dietary supplement use in the United States, 2003–2006. J Nutr 141(2):261–266. doi:10.3945/jn.110.133025 CrossRef
59.Park YK, Kim I, Yetley EA (1991) Characteristics of vitamin and mineral supplement products in the United States. Am J Clin Nutr 54(4):750–759 - 作者单位：Einat Avital Schmutz (1)
Michael Bruce Zimmermann (1)
Sabine Rohrmann (2)
1. Laboratory of Human Nutrition, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland
2. Department of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland - 刊物类别：Chemistry and Materials Science
- 刊物主题：Chemistry
Nutrition - 出版者：Springer Berlin / Heidelberg
- ISSN：1436-6215
文摘
Background Low serum 25-hydroxyvitamin D [25(OH)D] levels have been associated with higher risk of many diseases that affect mortality, including cardiovascular disease (CVD) and cancer. The inverse association between serum 25(OH)D and mortality may be modified by excess circulating vitamin A, due to interactions of vitamin A at the level of the vitamin D nuclear receptor. In this prospective cohort study, we investigated whether the association of 25(OH)D with all-cause, cancer, and CVD mortality was modified by circulating vitamin A or preformed vitamin A intake from supplements.